APO Research

APO RESEARCH · REPORT

Home Neuromodulation Device

Selected research

Market Analysis & Forecast

Global Home Neuromodulation Device Market Analysis and Forecast 2026-2032

Market perspective

The global Home Neuromodulation Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Home Neuromodulation Device's global sales reached XX (Units) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned NeuroSky as the global sales leader, a title it has maintained for several consecutive years. Notably, NeuroSky's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Units), a change of XX% from the previous year. In Europe, sales were XX (Units), showing a year-on-year of XX%. In the US, sales were XX (Units), a year-on-year change of XX%.

The major global manufacturers in the Home Neuromodulation Device market include NeuroSky, Emotiv, Thync, Muse and Halo Neuroscience, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Home Neuromodulation Device production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Home Neuromodulation Device by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Home Neuromodulation Device, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Home Neuromodulation Device, also provides the consumption of main regions and countries. Of the upcoming market potential for Home Neuromodulation Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Home Neuromodulation Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Home Neuromodulation Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Home Neuromodulation Device sales, projected growth trends, production technology, application and end-user industry.

Home Neuromodulation Device Segment by Company

NeuroSky

Emotiv

Thync

Muse

Halo Neuroscience

Home Neuromodulation Device Segment by Type

Brainwave Monitoring Equipment

Brain-Computer Interface Device

Neurofeedback Device

Others

Home Neuromodulation Device Segment by Application

Aldult

Child

Home Neuromodulation Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Neuromodulation Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Home Neuromodulation Device production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Home Neuromodulation Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Home Neuromodulation Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Home Neuromodulation Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Home Neuromodulation Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Brainwave Monitoring Equipment Major Manufacturers Table 3. Brain-Computer Interface Device Major Manufacturers Table 4. Neurofeedback Device Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Home Neuromodulation Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Aldult Major Manufacturers Table 8. Child Major Manufacturers Table 9. Home Neuromodulation Device Industry Trends Table 10. Home Neuromodulation Device Industry Drivers Table 11. Home Neuromodulation Device Industry Opportunities and Challenges Table 12. Home Neuromodulation Device Industry Restraints Table 13. Global Home Neuromodulation Device Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 14. Global Home Neuromodulation Device Production by Region (2021-2026) & (Units) Table 15. Global Home Neuromodulation Device Production by Region (2027-2032) & (Units) Table 16. Global Home Neuromodulation Device Production Market Share by Region (2021-2026) Table 17. Global Home Neuromodulation Device Production Market Share by Region (2027-2032) Table 18. Global Home Neuromodulation Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Home Neuromodulation Device Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Home Neuromodulation Device Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Home Neuromodulation Device Revenue Market Share by Region (2021-2026) Table 22. Global Home Neuromodulation Device Revenue Market Share by Region (2027-2032) Table 23. Global Home Neuromodulation Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 24. Global Home Neuromodulation Device Sales by Region (2021-2026) & (Units) Table 25. Global Home Neuromodulation Device Sales by Region (2027-2032) & (Units) Table 26. Global Home Neuromodulation Device Sales Market Share by Region (2021-2026) Table 27. Global Home Neuromodulation Device Sales Market Share by Region (2027-2032) Table 28. Global Home Neuromodulation Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Home Neuromodulation Device Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Home Neuromodulation Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Home Neuromodulation Device Sales Market Share by Manufacturers (2021-2026) Table 32. Global Home Neuromodulation Device Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Home Neuromodulation Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Home Neuromodulation Device Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Home Neuromodulation Device Manufacturers, Product Type & Application Table 36. Global Home Neuromodulation Device Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Home Neuromodulation Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Home Neuromodulation Device Revenue Market Share by Type (2021-2026) Table 42. Global Home Neuromodulation Device Revenue Market Share by Type (2027-2032) Table 43. Global Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 44. Global Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 45. Global Home Neuromodulation Device Sales Market Share by Type (2021-2026) Table 46. Global Home Neuromodulation Device Sales Market Share by Type (2027-2032) Table 47. Global Home Neuromodulation Device Price by Type (2021-2026) & (US$/Unit) Table 48. Global Home Neuromodulation Device Price by Type (2027-2032) & (US$/Unit) Table 49. Global Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Home Neuromodulation Device Revenue Market Share by Application (2021-2026) Table 52. Global Home Neuromodulation Device Revenue Market Share by Application (2027-2032) Table 53. Global Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 54. Global Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 55. Global Home Neuromodulation Device Sales Market Share by Application (2021-2026) Table 56. Global Home Neuromodulation Device Sales Market Share by Application (2027-2032) Table 57. Global Home Neuromodulation Device Price by Application (2021-2026) & (US$/Unit) Table 58. Global Home Neuromodulation Device Price by Application (2027-2032) & (US$/Unit) Table 59. NeuroSky Company Information Table 60. NeuroSky Business Overview Table 61. NeuroSky Home Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. NeuroSky Home Neuromodulation Device Product Portfolio Table 63. NeuroSky Recent Development Table 64. Emotiv Company Information Table 65. Emotiv Business Overview Table 66. Emotiv Home Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Emotiv Home Neuromodulation Device Product Portfolio Table 68. Emotiv Recent Development Table 69. Thync Company Information Table 70. Thync Business Overview Table 71. Thync Home Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Thync Home Neuromodulation Device Product Portfolio Table 73. Thync Recent Development Table 74. Muse Company Information Table 75. Muse Business Overview Table 76. Muse Home Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Muse Home Neuromodulation Device Product Portfolio Table 78. Muse Recent Development Table 79. Halo Neuroscience Company Information Table 80. Halo Neuroscience Business Overview Table 81. Halo Neuroscience Home Neuromodulation Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Halo Neuroscience Home Neuromodulation Device Product Portfolio Table 83. Halo Neuroscience Recent Development Table 84. North America Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 87. North America Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 88. North America Home Neuromodulation Device Sales Price by Type (2021-2026) & (US$/Unit) Table 89. North America Home Neuromodulation Device Sales Price by Type (2027-2032) & (US$/Unit) Table 90. North America Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 93. North America Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 94. North America Home Neuromodulation Device Sales Price by Application (2021-2026) & (US$/Unit) Table 95. North America Home Neuromodulation Device Sales Price by Application (2027-2032) & (US$/Unit) Table 96. North America Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Home Neuromodulation Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 98. North America Home Neuromodulation Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 99. North America Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 100. North America Home Neuromodulation Device Sales by Country (2021-2026) & (Units) Table 101. North America Home Neuromodulation Device Sales by Country (2027-2032) & (Units) Table 102. North America Home Neuromodulation Device Sales Price by Country (2021-2026) & (US$/Unit) Table 103. North America Home Neuromodulation Device Sales Price by Country (2027-2032) & (US$/Unit) Table 104. United States Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 105. Canada Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 106. Mexico Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 107. Europe Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 110. Europe Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 111. Europe Home Neuromodulation Device Sales Price by Type (2021-2026) & (US$/Unit) Table 112. Europe Home Neuromodulation Device Sales Price by Type (2027-2032) & (US$/Unit) Table 113. Europe Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 114. Europe Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 115. Europe Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 116. Europe Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 117. Europe Home Neuromodulation Device Sales Price by Application (2021-2026) & (US$/Unit) Table 118. Europe Home Neuromodulation Device Sales Price by Application (2027-2032) & (US$/Unit) Table 119. Europe Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Home Neuromodulation Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. Europe Home Neuromodulation Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. Europe Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 123. Europe Home Neuromodulation Device Sales by Country (2021-2026) & (Units) Table 124. Europe Home Neuromodulation Device Sales by Country (2027-2032) & (Units) Table 125. Europe Home Neuromodulation Device Sales Price by Country (2021-2026) & (US$/Unit) Table 126. Europe Home Neuromodulation Device Sales Price by Country (2027-2032) & (US$/Unit) Table 127. Germany Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 128. France Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 129. U.K. Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 130. Italy Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 131. Russia Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 132. Spain Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 133. Netherlands Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 134. Switzerland Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 135. Sweden Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 136. Poland Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 137. China Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 138. China Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 139. China Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 140. China Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 141. China Home Neuromodulation Device Sales Price by Type (2021-2026) & (US$/Unit) Table 142. China Home Neuromodulation Device Sales Price by Type (2027-2032) & (US$/Unit) Table 143. China Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 144. China Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 145. China Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 146. China Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 147. China Home Neuromodulation Device Sales Price by Application (2021-2026) & (US$/Unit) Table 148. China Home Neuromodulation Device Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 152. Asia Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 153. Asia Home Neuromodulation Device Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Asia Home Neuromodulation Device Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Asia Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 158. Asia Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 159. Asia Home Neuromodulation Device Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Asia Home Neuromodulation Device Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Home Neuromodulation Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Home Neuromodulation Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 165. Asia Home Neuromodulation Device Sales by Country (2021-2026) & (Units) Table 166. Asia Home Neuromodulation Device Sales by Country (2027-2032) & (Units) Table 167. Asia Home Neuromodulation Device Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Asia Home Neuromodulation Device Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Japan Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 170. South Korea Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 171. India Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 172. Australia Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 173. Taiwan Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Home Neuromodulation Device Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Home Neuromodulation Device Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Home Neuromodulation Device Sales by Type (2021-2026) & (Units) Table 178. SAMEA Home Neuromodulation Device Sales by Type (2027-2032) & (Units) Table 179. SAMEA Home Neuromodulation Device Sales Price by Type (2021-2026) & (US$/Unit) Table 180. SAMEA Home Neuromodulation Device Sales Price by Type (2027-2032) & (US$/Unit) Table 181. SAMEA Home Neuromodulation Device Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Home Neuromodulation Device Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Home Neuromodulation Device Sales by Application (2021-2026) & (Units) Table 184. SAMEA Home Neuromodulation Device Sales by Application (2027-2032) & (Units) Table 185. SAMEA Home Neuromodulation Device Sales Price by Application (2021-2026) & (US$/Unit) Table 186. SAMEA Home Neuromodulation Device Sales Price by Application (2027-2032) & (US$/Unit) Table 187. SAMEA Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Home Neuromodulation Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Home Neuromodulation Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 191. SAMEA Home Neuromodulation Device Sales by Country (2021-2026) & (Units) Table 192. SAMEA Home Neuromodulation Device Sales by Country (2027-2032) & (Units) Table 193. SAMEA Home Neuromodulation Device Sales Price by Country (2021-2026) & (US$/Unit) Table 194. SAMEA Home Neuromodulation Device Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Brazil Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 196. Argentina Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 197. Chile Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 198. Colombia Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 199. Peru Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 201. Israel Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 202. UAE Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 203. Turkey Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 204. Iran Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 205. Egypt Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Home Neuromodulation Device Distributors List Table 209. Home Neuromodulation Device Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Home Neuromodulation Device Product Image Figure 2. Global Home Neuromodulation Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Neuromodulation Device Market Size Share 2021 VS 2025 VS 2032 Figure . Brainwave Monitoring Equipment Image Figure 1. Brain-Computer Interface Device Image Figure 2. Neurofeedback Device Image Figure 3. Others Image Figure 4. Global Home Neuromodulation Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 5. Global Home Neuromodulation Device Market Size Share 2021 VS 2025 VS 2032 Figure 6. Aldult Image Figure 7. Child Image Figure 8. Global Home Neuromodulation Device Capacity, Capacity Utilization (2021-2032) & (Units) Figure 9. Global Home Neuromodulation Device Production by Region: 2021 VS 2025 VS 2032 (Units) Figure 10. Global Home Neuromodulation Device Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Home Neuromodulation Device Production Market Share by Region (2021-2032) Figure 12. North America Home Neuromodulation Device Production Growth Rate (2021-2032) & (Units) Figure 13. Europe Home Neuromodulation Device Production Growth Rate (2021-2032) & (Units) Figure 14. China Home Neuromodulation Device Production Growth Rate (2021-2032) & (Units) Figure 15. Japan Home Neuromodulation Device Production Growth Rate (2021-2032) & (Units) Figure 16. Global Home Neuromodulation Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Home Neuromodulation Device Revenue (2021-2032) & (US$ Million) Figure 18. Global Home Neuromodulation Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Home Neuromodulation Device Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Home Neuromodulation Device Revenue Market Share by Region (2021-2032) Figure 21. Global Home Neuromodulation Device Sales (2021-2032) & (Units) Figure 22. Global Home Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 23. Global Home Neuromodulation Device Sales Market Share by Region (2021-2032) Figure 24. North America Home Neuromodulation Device Sales YoY (2021-2032) & (Units) Figure 25. Europe Home Neuromodulation Device Sales YoY (2021-2032) & (Units) Figure 26. China Home Neuromodulation Device Sales YoY (2021-2032) & (Units) Figure 27. Asia (Excluding China) Home Neuromodulation Device Sales YoY (2021-2032) & (Units) Figure 28. South America, Middle East and Africa Home Neuromodulation Device Sales YoY (2021-2032) & (Units) Figure 29. Global Home Neuromodulation Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Home Neuromodulation Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Home Neuromodulation Device Revenue Market Share by Type (2021-2032) Figure 33. Global Home Neuromodulation Device Sales Market Share by Type (2021-2032) Figure 34. Global Home Neuromodulation Device Revenue Market Share by Application (2021-2032) Figure 35. Global Home Neuromodulation Device Sales Market Share by Application (2021-2032) Figure 36. North America Home Neuromodulation Device Revenue Share by Type (2021-2032) Figure 37. North America Home Neuromodulation Device Sales Share by Type (2021-2032) Figure 38. North America Home Neuromodulation Device Revenue Share by Application (2021-2032) Figure 39. North America Home Neuromodulation Device Sales Share by Application (2021-2032) Figure 40. North America Home Neuromodulation Device Revenue Share by Country (2021-2032) Figure 41. North America Home Neuromodulation Device Sales Share by Country (2021-2032) Figure 42. Europe Home Neuromodulation Device Revenue Share by Type (2021-2032) Figure 43. Europe Home Neuromodulation Device Sales Share by Type (2021-2032) Figure 44. Europe Home Neuromodulation Device Revenue Share by Application (2021-2032) Figure 45. Europe Home Neuromodulation Device Sales Share by Application (2021-2032) Figure 46. Europe Home Neuromodulation Device Revenue Share by Country (2021-2032) Figure 47. Europe Home Neuromodulation Device Sales Share by Country (2021-2032) Figure 48. China Home Neuromodulation Device Revenue Share by Type (2021-2032) Figure 49. China Home Neuromodulation Device Sales Share by Type (2021-2032) Figure 50. China Home Neuromodulation Device Revenue Share by Application (2021-2032) Figure 51. China Home Neuromodulation Device Sales Share by Application (2021-2032) Figure 52. Asia Home Neuromodulation Device Revenue Share by Type (2021-2032) Figure 53. Asia Home Neuromodulation Device Sales Share by Type (2021-2032) Figure 54. Asia Home Neuromodulation Device Revenue Share by Application (2021-2032) Figure 55. Asia Home Neuromodulation Device Sales Share by Application (2021-2032) Figure 56. Asia Home Neuromodulation Device Revenue Share by Country (2021-2032) Figure 57. Asia Home Neuromodulation Device Sales Share by Country (2021-2032) Figure 58. SAMEA Home Neuromodulation Device Revenue Share by Type (2021-2032) Figure 59. SAMEA Home Neuromodulation Device Sales Share by Type (2021-2032) Figure 60. SAMEA Home Neuromodulation Device Revenue Share by Application (2021-2032) Figure 61. SAMEA Home Neuromodulation Device Sales Share by Application (2021-2032) Figure 62. SAMEA Home Neuromodulation Device Revenue Share by Country (2021-2032) Figure 63. SAMEA Home Neuromodulation Device Sales Share by Country (2021-2032) Figure 64. Home Neuromodulation Device Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Home Neuromodulation Device Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Brainwave Monitoring Equipment
  • Brain-Computer Interface Device
  • Neurofeedback Device
  • Others
Applications
  • Aldult
  • Child
Companies covered
  • NeuroSky
  • Emotiv
  • Thync
  • Muse
  • Halo Neuroscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Home Neuromodulation Device Market by Type
  3. 1.2.1 Global Home Neuromodulation Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Brainwave Monitoring Equipment
  5. 1.2.3 Brain-Computer Interface Device
  6. 1.2.4 Neurofeedback Device
  7. 1.2.5 Others
  8. 1.3 Home Neuromodulation Device Market by Application
  9. 1.3.1 Global Home Neuromodulation Device Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Aldult
  11. 1.3.3 Child
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Home Neuromodulation Device Market Dynamics
  1. 2.1 Home Neuromodulation Device Industry Trends
  2. 2.2 Home Neuromodulation Device Industry Drivers
  3. 2.3 Home Neuromodulation Device Industry Opportunities and Challenges
  4. 2.4 Home Neuromodulation Device Industry Restraints
3 Global Home Neuromodulation Device Production Overview
  1. 3.1 Global Home Neuromodulation Device Production Capacity (2021-2032)
  2. 3.2 Global Home Neuromodulation Device Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Home Neuromodulation Device Production by Region
  4. 3.3.1 Global Home Neuromodulation Device Production by Region (2021-2026)
  5. 3.3.2 Global Home Neuromodulation Device Production by Region (2027-2032)
  6. 3.3.3 Global Home Neuromodulation Device Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Home Neuromodulation Device Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Home Neuromodulation Device Revenue by Region
  3. 4.2.1 Global Home Neuromodulation Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Home Neuromodulation Device Revenue by Region (2021-2026)
  5. 4.2.3 Global Home Neuromodulation Device Revenue by Region (2027-2032)
  6. 4.2.4 Global Home Neuromodulation Device Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Home Neuromodulation Device Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Home Neuromodulation Device Sales by Region
  9. 4.4.1 Global Home Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Home Neuromodulation Device Sales by Region (2021-2026)
  11. 4.4.3 Global Home Neuromodulation Device Sales by Region (2027-2032)
  12. 4.4.4 Global Home Neuromodulation Device Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Home Neuromodulation Device Revenue by Manufacturers
  2. 5.1.1 Global Home Neuromodulation Device Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Home Neuromodulation Device Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Home Neuromodulation Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Home Neuromodulation Device Sales by Manufacturers
  6. 5.2.1 Global Home Neuromodulation Device Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Home Neuromodulation Device Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Home Neuromodulation Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Home Neuromodulation Device Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Home Neuromodulation Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Home Neuromodulation Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Home Neuromodulation Device Manufacturers, Product Type & Application
  13. 5.7 Global Home Neuromodulation Device Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Home Neuromodulation Device Market CR5 and HHI
  16. 5.8.2 2025 Home Neuromodulation Device Tier 1, Tier 2, and Tier 3
6 Home Neuromodulation Device Market by Type
  1. 6.1 Global Home Neuromodulation Device Revenue by Type
  2. 6.1.1 Global Home Neuromodulation Device Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Home Neuromodulation Device Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Home Neuromodulation Device Sales by Type
  5. 6.2.1 Global Home Neuromodulation Device Sales by Type (2021-2032) & (Units)
  6. 6.2.2 Global Home Neuromodulation Device Sales Market Share by Type (2021-2032)
  7. 6.3 Global Home Neuromodulation Device Price by Type
7 Home Neuromodulation Device Market by Application
  1. 7.1 Global Home Neuromodulation Device Revenue by Application
  2. 7.1.1 Global Home Neuromodulation Device Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Home Neuromodulation Device Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Home Neuromodulation Device Sales by Application
  5. 7.2.1 Global Home Neuromodulation Device Sales by Application (2021-2032) & (Units)
  6. 7.2.2 Global Home Neuromodulation Device Sales Market Share by Application (2021-2032)
  7. 7.3 Global Home Neuromodulation Device Price by Application
8 Company Profiles
  1. 8.1 NeuroSky
  2. 8.1.1 NeuroSky Company Information
  3. 8.1.2 NeuroSky Business Overview
  4. 8.1.3 NeuroSky Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 NeuroSky Home Neuromodulation Device Product Portfolio
  6. 8.1.5 NeuroSky Recent Developments
  7. 8.2 Emotiv
  8. 8.2.1 Emotiv Company Information
  9. 8.2.2 Emotiv Business Overview
  10. 8.2.3 Emotiv Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Emotiv Home Neuromodulation Device Product Portfolio
  12. 8.2.5 Emotiv Recent Developments
  13. 8.3 Thync
  14. 8.3.1 Thync Company Information
  15. 8.3.2 Thync Business Overview
  16. 8.3.3 Thync Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Thync Home Neuromodulation Device Product Portfolio
  18. 8.3.5 Thync Recent Developments
  19. 8.4 Muse
  20. 8.4.1 Muse Company Information
  21. 8.4.2 Muse Business Overview
  22. 8.4.3 Muse Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Muse Home Neuromodulation Device Product Portfolio
  24. 8.4.5 Muse Recent Developments
  25. 8.5 Halo Neuroscience
  26. 8.5.1 Halo Neuroscience Company Information
  27. 8.5.2 Halo Neuroscience Business Overview
  28. 8.5.3 Halo Neuroscience Home Neuromodulation Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Halo Neuroscience Home Neuromodulation Device Product Portfolio
  30. 8.5.5 Halo Neuroscience Recent Developments
9 North America
  1. 9.1 North America Home Neuromodulation Device Market Size by Type
  2. 9.1.1 North America Home Neuromodulation Device Revenue by Type (2021-2032)
  3. 9.1.2 North America Home Neuromodulation Device Sales by Type (2021-2032)
  4. 9.1.3 North America Home Neuromodulation Device Price by Type (2021-2032)
  5. 9.2 North America Home Neuromodulation Device Market Size by Application
  6. 9.2.1 North America Home Neuromodulation Device Revenue by Application (2021-2032)
  7. 9.2.2 North America Home Neuromodulation Device Sales by Application (2021-2032)
  8. 9.2.3 North America Home Neuromodulation Device Price by Application (2021-2032)
  9. 9.3 North America Home Neuromodulation Device Market Size by Country
  10. 9.3.1 North America Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Home Neuromodulation Device Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Home Neuromodulation Device Market Size by Type
  2. 10.1.1 Europe Home Neuromodulation Device Revenue by Type (2021-2032)
  3. 10.1.2 Europe Home Neuromodulation Device Sales by Type (2021-2032)
  4. 10.1.3 Europe Home Neuromodulation Device Price by Type (2021-2032)
  5. 10.2 Europe Home Neuromodulation Device Market Size by Application
  6. 10.2.1 Europe Home Neuromodulation Device Revenue by Application (2021-2032)
  7. 10.2.2 Europe Home Neuromodulation Device Sales by Application (2021-2032)
  8. 10.2.3 Europe Home Neuromodulation Device Price by Application (2021-2032)
  9. 10.3 Europe Home Neuromodulation Device Market Size by Country
  10. 10.3.1 Europe Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Home Neuromodulation Device Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Home Neuromodulation Device Market Size by Type
  2. 11.1.1 China Home Neuromodulation Device Revenue by Type (2021-2032)
  3. 11.1.2 China Home Neuromodulation Device Sales by Type (2021-2032)
  4. 11.1.3 China Home Neuromodulation Device Price by Type (2021-2032)
  5. 11.2 China Home Neuromodulation Device Market Size by Application
  6. 11.2.1 China Home Neuromodulation Device Revenue by Application (2021-2032)
  7. 11.2.2 China Home Neuromodulation Device Sales by Application (2021-2032)
  8. 11.2.3 China Home Neuromodulation Device Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Home Neuromodulation Device Market Size by Type
  2. 12.1.1 Asia Home Neuromodulation Device Revenue by Type (2021-2032)
  3. 12.1.2 Asia Home Neuromodulation Device Sales by Type (2021-2032)
  4. 12.1.3 Asia Home Neuromodulation Device Price by Type (2021-2032)
  5. 12.2 Asia Home Neuromodulation Device Market Size by Application
  6. 12.2.1 Asia Home Neuromodulation Device Revenue by Application (2021-2032)
  7. 12.2.2 Asia Home Neuromodulation Device Sales by Application (2021-2032)
  8. 12.2.3 Asia Home Neuromodulation Device Price by Application (2021-2032)
  9. 12.3 Asia Home Neuromodulation Device Market Size by Country
  10. 12.3.1 Asia Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Home Neuromodulation Device Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Home Neuromodulation Device Market Size by Type
  2. 13.1.1 SAMEA Home Neuromodulation Device Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Home Neuromodulation Device Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Home Neuromodulation Device Price by Type (2021-2032)
  5. 13.2 SAMEA Home Neuromodulation Device Market Size by Application
  6. 13.2.1 SAMEA Home Neuromodulation Device Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Home Neuromodulation Device Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Home Neuromodulation Device Price by Application (2021-2032)
  9. 13.3 SAMEA Home Neuromodulation Device Market Size by Country
  10. 13.3.1 SAMEA Home Neuromodulation Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Home Neuromodulation Device Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Home Neuromodulation Device Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Home Neuromodulation Device Value Chain Analysis
  2. 14.1.1 Home Neuromodulation Device Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Home Neuromodulation Device Production Mode & Process
  6. 14.2 Home Neuromodulation Device Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Home Neuromodulation Device Distributors
  9. 14.2.3 Home Neuromodulation Device Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research